Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Cardiff Oncology, Inc. (CRDF)

NASDAQ

$1.61

$+0.02

(+1.27%)

Cardiff Oncology, Inc. (CRDF) Live Price Chart

Page last updated: 2026-04-13 18:56:00

Key Market Data

Market Cap	$109.73M
Open	$1.57
High	$25.50
Low	$0.82
Previous Close	$1.58
Price Change	$+0.02
Percentage Change	+1.27%
Volume	586K

Cardiff Oncology, Inc. (CRDF) Stock Price Today

Cardiff Oncology, Inc. (CRDF) is currently trading at $1.61 as of 2026-04-13 18:56:00, reflecting a +1.27% move ($+0.02) from the previous close.

In the short term, the stock has returned -15.53% over the past four weeks. Over the last 12 months, Cardiff Oncology, Inc. has recorded a -42.47% price change, indicating a Weak performance relative to the broader market.

Cardiff Oncology, Inc. (CRDF) 7-Day Stock Price Changes

Over the past seven days, Cardiff Oncology, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $1.58 to the latest recorded price of $1.61, reflecting an intraday change of +1.27%. Daily movements highlight shifts in trading volume (585,837), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, CRDF has delivered a -15.53% return over the past month and a -42.47% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy Cardiff Oncology, Inc. (CRDF)

You can buy and trade CRDF on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for CRDF and Execute Your Trade

Open the trading page, enter CRDF in the search bar, select the amount of CRDF you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Cardiff Oncology, Inc. (CRDF)?

Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

Cardiff Oncology, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	31
Sector	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Website	https://www.cardiffoncology.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Cardiff Oncology, Inc.?

The latest trading price for Cardiff Oncology, Inc. (Common Stock) is $ 1.61, compared with a previous closing price of $ 1.58. That means the stock has moved +1.27% so far today. Intraday price updates and recent trading activity for CRDF can be tracked on the live chart and quote section on this page.

2.Is Cardiff Oncology, Inc. stock going up or down?

Looking at recent performances, CRDF has returned -15.53% over the past month, -28.35% over the last six months and -42.47% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for Cardiff Oncology, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does CRDF currently sit relative to its 52-week high and low?

In the most recent 52-week period, Cardiff Oncology, Inc. has traded between a low of $ 1.48 and a high of $ 4.56. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether CRDF is currently nearer the top or the bottom of its one-year trading band.

4.How is Cardiff Oncology, Inc. classified by sector and industry?

Cardiff Oncology, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. In practice, this means Cardiff Oncology, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing CRDF’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector could influence Cardiff Oncology, Inc.’s performance.

5.Where is Cardiff Oncology, Inc. listed and how large is it by market value?

Cardiff Oncology, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 109.73M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Cardiff Oncology, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does CRDF's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.67 summarises how much profit Cardiff Oncology, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Cardiff Oncology, Inc.'s financial performance over time?

To follow Cardiff Oncology, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how CRDF is performing and how the market is responding.

8.When is Cardiff Oncology, Inc. expected to report earnings?

Cardiff Oncology, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for CRDF, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Cardiff Oncology, Inc.'s earnings reports?

Cardiff Oncology, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether CRDF is meeting, beating or missing expectations.

10.How can I stay informed about Cardiff Oncology, Inc.'s results and guidance?

You can stay up to date on Cardiff Oncology, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for CRDF on this page helps you see how new information is being reflected in the stock.

11.Does Cardiff Oncology, Inc. pay a regular cash dividend to its shareholders?

Cardiff Oncology, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor CRDF's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for CRDF?

Based on the latest earnings data, CRDF has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Cardiff Oncology, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Cardiff Oncology, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Cardiff Oncology, Inc.?

Cardiff Oncology, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is CRDF valued in terms of P/E ratio and EPS?

Cardiff Oncology, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.67. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Cardiff Oncology, Inc.'s earnings. Comparing CRDF's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Valero Energy Corporation

VLO

Spire Inc.

Stellar Bancorp, Inc.

STEL

Boyd Gaming Corporation

BYD

VERMILION ENERGY INC.

VET

Top Gainers

Browse today's leading gainers in the US stock market

Real Messenger Corporation

RMSG

Creative Media & Community Trust Corporation

CMCT

RedCloud Holdings plc

RCT

Rectitude Holdings Ltd

RECT

Bitcoin Depot Inc.

BTM

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

CRDF-to-USD Calculator

Amount

CRDF

USD

1 CRDF = 1.605 USD